ABCC4 and colorectal carcinoma: The CRC subgroup characterised by high expression of ABCC4 shows substantial dependence on EMT reprogramming (acquired via TMEM interaction) and RNA metabolism, with higher response to DNA damage stimuli and rather good response to oxaliplatin-based FOLFOX treatment that primarily focuses on the formation of DNA-platinum adducts.